CR
CorMedix Inc.
CRMD · NASDAQ
$7.72 +0.46% (+$0.04)
1M -6.20%
Market Cap $611.1M
P/E Ratio 3.27x
Div. Yield -
ROE 44.64%
Bulios Fair Price
$5.98
22.5% downside
Trenutna cena
$7.72
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CRMD trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 1.33x
P/S 1.32x
P/E 3.27x
Growth
100 /100
Growing Book val. growth 94.53%
Rev. growth 1,582.83%
FCF growth N/A
Profitability
100 /100
Strong FCF margin 54.45%
Op. margin 46.95%
Gross margin 82.78%
Quality
91 /100
Excellent Asset turnover 0.51x
ROA 20.70%
ROIC 27.87%
Debt
100 /100
Low Net debt/EBITDA -0.45x
Int. coverage 77.58x
Debt/Equity 0.31x
Stability
16 /100
Unstable EPS volatility 439.92%
Profitable years 1
Beta 1.50x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRMD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph Todisco
Employees
191
Headquarters
Parsippany
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report